ESCRT requirements for murine leukemia virus release

Viruses

Volumn 8, Issue 4, 2016, Pages

  Bartusch, Christina ^a   Prange, Reinhild ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

CHMP1A; ESCRT; MLV; MVB pathway; Retroviral budding; Viral late domain; VLPs

Indexed keywords

ANTIBODY; CHARGED MULTIVESICULAR BODY PROTEIN 1A; CHARGED MULTIVESICULAR BODY PROTEIN 4B; ESCRT PROTEIN; ESCRT PROTEIN 3; MEMBRANE PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; GAG PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOLYSIS; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE SILENCING; GENETIC ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MULTIVESICULAR BODY; MURINE LEUKEMIA VIRUS; MUTAGENESIS; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LIKE AGENT; VIRUS PARTICLE; VIRUS RELEASE; WESTERN BLOTTING; ANIMAL; CELL LINE; GENE ORDER; GENE VECTOR; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; RETROVIRUS INFECTION; VIROLOGY;

ANIMALS; CELL LINE; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENE ORDER; GENE PRODUCTS, GAG; GENETIC VECTORS; HUMANS; LEUKEMIA VIRUS, MURINE; MICE; RETROVIRIDAE INFECTIONS; VIRUS RELEASE;

EID: 84964309654     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8040103     Document Type: Article

References (58)

1. McCullough, J., Colf, L.A., Sundquist, W.I. Membrane fission reactions of the mammalian ESCRT pathway. Annu. Rev. Biochem. 2013, 82, 663-692. [CrossRef] [PubMed]
2. Jimenez, A.J., Maiuri, P., Lafaurie-Janvore, J., Divoux, S., Piel, M., Perez, F. ESCRT machinery is required for plasma membrane repair. Science 2014, 343. [CrossRef] [PubMed]
3. Votteler, J., Sundquist, W.I. Virus budding and the ESCRT pathway. Cell Host Microbe 2013, 14, 232-241. [CrossRef] [PubMed]
4. Hurley, J.H. ESCRTs are everywhere. EMBO J. 2015, 34, 2398-2407. [CrossRef] [PubMed]
5. Martin-Serrano, J., Neil, S.J. Host factors involved in retroviral budding and release. Nat. Rev. Microbiol. 2011, 9, 519-531. [CrossRef] [PubMed]
6. Morita, E. Differential requirements of mammalian ESCRTs in multivesicular body formation, virus budding and cell division. FEBS J. 2012, 279, 1399-1406. [CrossRef] [PubMed]
7. Peel, S., Macheboeuf, P., Martinelli, N., Weissenhorn, W. Divergent pathways lead to ESCRT-III-catalyzed membrane fission. Trends Biochem. Sci. 2011, 36, 199-210. [CrossRef] [PubMed]
8. Langelier, C., von Schwedler, U.K., Fisher, R.D., de Domenico, I., White, P.L., Hill, C.P., Kaplan, J., Ward, D., Sundquist, W.I. Human ESCRT-II complex and its role in human immunodeficiency virus type 1 release. J. Virol. 2006, 80, 9465-9480. [CrossRef] [PubMed]
9. Yorikawa, C., Shibata, H., Waguri, S., Hatta, K., Horii, M., Katoh, K., Kobayashi, T., Uchiyama, Y., Maki, M. Human CHMP6, a myristoylated ESCRT-III protein, interacts directly with an ESCRT-II component EAP20 and regulates endosomal cargo sorting. Biochem. J. 2005, 387, 17-26. [CrossRef] [PubMed]
10. Bieniasz, P.D. Late budding domains and host proteins in enveloped virus release. Virology 2006, 344, 55-63. [CrossRef] [PubMed]
11. Demirov, D.G., Freed, E.O. Retrovirus budding. Virus Res. 2004, 106, 87-102. [CrossRef] [PubMed]
12. Gottlinger, H.G., Dorfman, T., Sodroski, J.G., Haseltine, W.A. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. USA 1991, 88, 3195-3199. [CrossRef] [PubMed]
13. Wills, J.W., Cameron, C.E., Wilson, C.B., Xiang, Y., Bennett, R.P., Leis, J. An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J. Virol. 1994, 68, 6605-6618. [PubMed]
14. VerPlank, L., Bouamr, F., LaGrassa, T.J., Agresta, B., Kikonyogo, A., Leis, J., Carter, C.A. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag. Proc. Natl. Acad. Sci. USA 2001, 98, 7724-7729. [CrossRef] [PubMed]
15. Carlson, L.A., Hurley, J.H. In vitro reconstitution of the ordered assembly of the endosomal sorting complex required for transport at membrane-bound HIV-1 Gag clusters. Proc. Natl. Acad. Sci. USA 2012, 109, 16928-16933. [CrossRef] [PubMed]
16. Meng, B., Ip, N.C., Prestwood, L.J., Abbink, T.E., Lever, A.M. Evidence that the endosomal sorting complex required for transport-II (ESCRT-II) is required for efficient human immunodeficiency virus-1 (HIV-1) production. Retrovirology 2015, 12. [CrossRef] [PubMed]
17. Stieler, J.T., Prange, R. Involvement of ESCRT-II in hepatitis B virus morphogenesis. PLoS ONE 2014, 9, e91279. [CrossRef] [PubMed]
18. Pincetic, A., Medina, G., Carter, C., Leis, J. Avian sarcoma virus and human immunodeficiency virus, type 1 use different subsets of ESCRT proteins to facilitate the budding process. J. Biol. Chem. 2008, 283, 29822-29830. [CrossRef] [PubMed]
19. Segura-Morales, C., Pescia, C., Chatellard-Causse, C., Sadoul, R., Bertrand, E., Basyuk, E. Tsg101 and Alix interact with murine leukemia virus Gag and cooperate with Nedd4 ubiquitin ligases during budding. J. Biol. Chem. 2005, 280, 27004-27012. [CrossRef] [PubMed]
20. Jadwin, J.A., Rudd, V., Sette, P., Challa, S., Bouamr, F. Late domain-independent rescue of a release-deficient Moloney murine leukemia virus by the ubiquitin ligase itch. J. Virol. 2010, 84, 704-715. [CrossRef] [PubMed]
21. Rauch, S., Martin-Serrano, J. Multiple interactions between the ESCRT machinery and arrestin-related proteins: Implications for PPXY-dependent budding. J. Virol. 2011, 85, 3546-3556. [CrossRef] [PubMed]
22. Kikonyogo, A., Bouamr, F., Vana, M.L., Xiang, Y., Aiyar, A., Carter, C., Leis, J. Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc. Natl. Acad. Sci. USA 2001, 98, 11199-11204. [CrossRef] [PubMed]
23. Weiss, E.R., Popova, E., Yamanaka, H., Kim, H.C., Huibregtse, J.M., Gottlinger, H. Rescue of HIV-1 release by targeting widely divergent NEDD4-type ubiquitin ligases and isolated catalytic HECT domains to Gag. PLoS Pathog. 2010, 6, e1001107. [CrossRef] [PubMed]
24. Chung, H.Y., Morita, E., von Schwedler, U., Muller, B., Krausslich, H.G., Sundquist, W.I. NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains. J. Virol. 2008, 82, 4884-4897. [CrossRef] [PubMed]
25. Yuan, B., Li, X., Goff, S.P. Mutations altering the moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle. EMBO J. 1999, 18, 4700-4710. [CrossRef] [PubMed]
26. Rein, A. Murine leukemia viruses: Objects and organisms. Adv. Virol. 2011, 2011, 403419. [CrossRef] [PubMed]
27. Andrawiss, M., Takeuchi, Y., Hewlett, L., Collins, M. Murine leukemia virus particle assembly quantitated by fluorescence microscopy: Role of Gag-Gag interactions and membrane association. J. Virol. 2003, 77, 11651-11660. [CrossRef] [PubMed]
28. Sherer, N.M., Lehmann, M.J., Jimenez-Soto, L.F., Ingmundson, A., Horner, S.M., Cicchetti, G., Allen, P.G., Pypaert, M., Cunningham, J.M., Mothes, W. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 2003, 4, 785-801. [CrossRef] [PubMed]
29. Thomas, C.E., Ehrhardt, A., Kay, M.A. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 2003, 4, 346-358. [CrossRef] [PubMed]
30. Naviaux, R.K., Costanzi, E., Haas, M., Verma, I.M. The pCL vector system: Rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 1996, 70, 5701-5705. [PubMed]
31. Yueh, A., Goff, S.P. Phosphorylated serine residues and an arginine-rich domain of the moloney murine leukemia virus p12 protein are required for early events of viral infection. J. Virol. 2003, 77, 1820-1829. [CrossRef] [PubMed]
32. Erlwein, O., Buchholz, C.J., Schnierle, B.S. The proline-rich region of the ecotropic Moloney murine leukaemia virus envelope protein tolerates the insertion of the green fluorescent protein and allows the generation of replication-competent virus. J. Gen. Virol. 2003, 84, 369-373. [CrossRef] [PubMed]
33. Wang, X., Seed, B. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res. 2003, 31, 1-8. [CrossRef]
34. Martin-Serrano, J., Eastman, S.W., Chung, W., Bieniasz, P.D. HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. J. Cell Biol. 2005, 168, 89-101. [CrossRef] [PubMed]
35. Goliand, I., Nachmias, D., Gershony, O., Elia, N. Inhibition of ESCRT-II-CHMP6 interactions impedes cytokinetic abscission and leads to cell death. Mol. Biol. Cell 2014, 25, 3740-3748. [CrossRef] [PubMed]
36. Lambert, C., Doring, T., Prange, R. Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin. J. Virol. 2007, 81, 9050-9060. [CrossRef] [PubMed]
37. Agromayor, M., Martin-Serrano, J. Interaction of AMSH with ESCRT-III and deubiquitination of endosomal cargo. J. Biol. Chem. 2006, 281, 23083-23091. [CrossRef] [PubMed]
38. Houzet, L., Gay, B., Morichaud, Z., Briant, L., Mougel, M. Intracellular assembly and budding of the Murine Leukemia Virus in infected cells. Retrovirology 2006, 3. [CrossRef] [PubMed]
39. Zhang, F., Zang, T., Wilson, S.J., Johnson, M.C., Bieniasz, P.D. Clathrin facilitates the morphogenesis of retrovirus particles. PLoS Pathog. 2011, 7, e1002119. [CrossRef] [PubMed]
40. Prange, R. Host factors involved in hepatitis B virus maturation, assembly, and egress. Med. Microbiol. Immunol. 2012, 201, 449-461. [CrossRef] [PubMed]
41. Irie, T., Shimazu, Y., Yoshida, T., Sakaguchi, T. The YLDL sequence within Sendai virus M protein is critical for budding of virus-like particles and interacts with Alix/AIP1 independently of C protein. J. Virol. 2007, 81, 2263-2273. [CrossRef] [PubMed]
42. Gosselin-Grenet, A.S., Marq, J.B., Abrami, L., Garcin, D., Roux, L. Sendai virus budding in the course of an infection does not require Alix and VPS4A host factors. Virology 2007, 365, 101-112. [CrossRef] [PubMed]
43. Chou, S.F., Tsai, M.L., Huang, J.Y., Chang, Y.S., Shih, C. The dual role of an ESCRT-0 component HGS in HBV transcription and naked capsid secretion. PLoS Pathog. 2015, 11, e1005123. [CrossRef] [PubMed]
44. Morita, E., Sandrin, V., McCullough, J., Katsuyama, A., Baci Hamilton, I., Sundquist, W.I. ESCRT-III protein requirements for HIV-1 budding. Cell Host Microbe 2011, 9, 235-242. [CrossRef] [PubMed]
45. Ward, D.M., Vaughn, M.B., Shiflett, S.L., White, P.L., Pollock, A.L., Hill, J., Schnegelberger, R., Sundquist, W.I., Kaplan, J. The role of LIP5 and CHMP5 in multivesicular body formation and HIV-1 budding in mammalian cells. J. Biol. Chem. 2005, 280, 10548-10555. [CrossRef] [PubMed]
46. Katoh, K., Shibata, H., Hatta, K., Maki, M. CHMP4b is a major binding partner of the ALG-2-interacting protein Alix among the three CHMP4 isoforms. Arch. Biochem. Biophys. 2004, 421, 159-165. [CrossRef] [PubMed]
47. Bodon, G., Chassefeyre, R., Pernet-Gallay, K., Martinelli, N., Effantin, G., Hulsik, D.L., Belly, A., Goldberg, Y., Chatellard-Causse, C., Blot, B., et al. Charged multivesicular body protein 2B (CHMP2B) of the endosomal sorting complex required for transport-III (ESCRT-III) polymerizes into helical structures deforming the plasma membrane. J. Biol. Chem. 2011, 286, 40276-40286. [CrossRef] [PubMed]
48. Effantin, G., Dordor, A., Sandrin, V., Martinelli, N., Sundquist, W.I., Schoehn, G., Weissenhorn, W. ESCRT-III CHMP2A and CHMP3 form variable helical polymers in vitro and act synergistically during HIV-1 budding. Cell Microbiol. 2013, 15, 213-226. [CrossRef] [PubMed]
49. Stuchell-Brereton, M.D., Skalicky, J.J., Kieffer, C., Karren, M.A., Ghaffarian, S., Sundquist, W.I. ESCRT-III recognition by VPS4 ATPases. Nature 2007, 449, 740-744. [CrossRef] [PubMed]
50. Wollert, T., Wunder, C., Lippincott-Schwartz, J., Hurley, J.H. Membrane scission by the ESCRT-III complex. Nature 2009, 458, 172-177. [CrossRef] [PubMed]
51. Shim, S., Merrill, S.A., Hanson, P.I. Novel interactions of ESCRT-III with LIP5 and VPS4 and their implications for ESCRT-III disassembly. Mol. Biol. Cell 2008, 19, 2661-2672. [CrossRef] [PubMed]
52. Vild, C.J., Li, Y., Guo, E.Z., Liu, Y., Xu, Z. A novel mechanism of regulating the ATPase VPS4 by its cofactor LIP5 and the endosomal sorting complex required for transport (ESCRT)-III protein CHMP5. J. Biol. Chem. 2015, 290, 7291-7303. [CrossRef] [PubMed]
53. Sandrin, V., Sundquist, W.I. ESCRT requirements for EIAV budding. Retrovirology 2013, 10. [CrossRef] [PubMed]
54. Parkinson, M.D., Piper, S.C., Bright, N.A., Evans, J.L., Boname, J.M., Bowers, K., Lehner, P.J., Luzio, J.P. A non-canonical ESCRT pathway, including histidine domain phosphotyrosine phosphatase (HD-PTP), is used for down-regulation of virally ubiquitinated MHC class I. Biochem. J. 2015, 471, 79-88. [CrossRef] [PubMed]
55. Maemoto, Y., Shibata, H., Maki, M. Identification of phosphorylation sites in the C-terminal region of charged multivesicular body protein 1A (CHMP1A). Biosci. Biotechnol. Biochem. 2013, 77, 1317-1319. [CrossRef] [PubMed]
56. Tsang, H.T., Connell, J.W., Brown, S.E., Thompson, A., Reid, E., Sanderson, C.M. A systematic analysis of human CHMP protein interactions: Additional MIT domain-containing proteins bind to multiple components of the human ESCRT III complex. Genomics 2006, 88, 333-346. [CrossRef] [PubMed]
57. Park, M. Posttranslational modifications of CHMP1A and their effects on human pancreatic cancer cells. In Proceedings of the AACR Special Conference on Pancreatic Cancer: Innovations in Research and Treatment, New Orleans, LA, USA, 18-21 May 2014; AACR: Philadelphia, PA, USA, 2015; Volume 75.
58. Carlton, J.G., Caballe, A., Agromayor, M., Kloc, M., Martin-Serrano, J. ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C. Science 2012, 336, 220-225. [CrossRef] [PubMed]